- Research works
- 59 ▼ 33% vs 2013–17
- Citations
- 588 9.9 per fractional work
- Top-10% rate
- 6.3% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Retriev Technologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 24.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 24.2×
- Veterinary 15.2×
- Chemistry 5.4×
- Neuroscience 2.4×
- Environmental Science 2.3×
- Medicine 2.0×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Nursing 1.3×
- Agricultural and Biological Sciences 1.0×
- Business, Management and Accounting 0.8×
- Computer Science 0.8×
- Immunology and Microbiology 0.6×
- Health Professions 0.2×
- Social Sciences 0.1×
Who are the top researchers at Retriev Technologies (United States)?
Ranked on the composite score, Douglas J. Jolly lead among researchers whose main affiliation is Retriev Technologies (United States).
- 1 Douglas J. Jolly United States · #366,786 worldwide 101 citations · 24 works
Which keywords describe research at Retriev Technologies (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Tumor Regression, Genomic Integration, AAV, Viral Vectors, Tumor Targeting and Arginine Deprivation.
- Fungal Pathogens
- Pharmacokinetics
- Workplace Safety
- Immune Response
- Comet Assay
- Environmental Monitoring
- Bisphenol A
- Toxicology
- Environmental Exposure
- CAR T Cells
- Lymphoma
- Cancer
- Biomarkers
- Glioblastoma
- Oxidative Stress
- Health Effects
- Arginine Deprivation
- Viral Vectors
- Genomic Integration
- Gene Therapy
- Immunotherapy
- Tumor Regression
- AAV
- Tumor Targeting
- Bacterial Therapy
- Risk Assessment
- Radiotherapy
- Temozolomide
- DNA Damage
- Genome Engineering
- RNA-Guided
- Chimeric Antigen Receptor
- Nanoparticles
- Reactive Oxygen Species
- Endocrine-Disrupting Chemicals
- Food Safety
- Genotoxicity Testing
- Tumor Microenvironment
- Pesticides
- Cardiovascular Diseases
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy11▲ 29×8 topics
- Gene Therapy10▲ 66×3 topics
- Tumor Regression6▲ 123×2 topics
- Genomic Integration6▲ 95×2 topics
- AAV6▲ 150×1 topic
- Viral Vectors6▲ 150×1 topic
- Tumor Targeting5▲ 61×2 topics
- Arginine Deprivation4▲ 166×1 topic
- Bacterial Therapy4▲ 166×1 topic
- Health Effects4▲ 11×7 topics
- Risk Assessment3▲ 9.8×7 topics
- Oxidative Stress3▲ 3.0×8 topics
- Radiotherapy3▲ 15×2 topics
- Glioblastoma3▲ 90×1 topic
- Temozolomide3▲ 90×1 topic
- Biomarkers2▲ 6.0×7 topics
- DNA Damage2▲ 28×3 topics
- Cancer2▲ 2.5×9 topics
- Genome Engineering2▲ 62×1 topic
- Lymphoma2▲ 24×3 topics
- RNA-Guided2▲ 62×1 topic
- CAR T Cells2▲ 79×1 topic
- Chimeric Antigen Receptor2▲ 79×1 topic
- Environmental Exposure2▲ 32×2 topics
- Nanoparticles2▲ 2.6×6 topics
- Toxicology2▲ 16×4 topics
- Reactive Oxygen Species2▲ 6.4×4 topics
- Bisphenol A2▲ 82×1 topic
- Endocrine-Disrupting Chemicals2▲ 82×1 topic
- Environmental Monitoring2▲ 9.6×3 topics
- Food Safety2▲ 10×6 topics
- Comet Assay2▲ 59×1 topic
- Genotoxicity Testing2▲ 59×1 topic
- Immune Response2▲ 4.0×7 topics
- Tumor Microenvironment1▲ 6.4×4 topics
- Workplace Safety1▲ 22×2 topics
- Pesticides1▲ 19×3 topics
- Pharmacokinetics1▲ 6.7×3 topics
- Cardiovascular Diseases1▲ 14×1 topic
- Fungal Pathogens1▲ 9.7×1 topic
Which research topics does Retriev Technologies (United States) publish most on?
By volume in 2022–2025: Effects and risks of endocrine disrupting chemicals, Botulinum Toxin and Related Neurological Disorders, Carcinogens and Genotoxicity Assessment and Olfactory and Sensory Function Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 1 works
- 2 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
- 3 Carcinogens and Genotoxicity Assessment Cancer Research 0 works
- 4 Olfactory and Sensory Function Studies Sensory Systems 0 works
- 5 Skin Protection and Aging Dermatology 0 works
- 6 Chemical synthesis and pharmacological studies Organic Chemistry 0 works
- 7 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 0 works
- 8 Synthesis and Reactions of Organic Compounds Organic Chemistry 0 works
- 9 Medical and Pharmaceutic Studies Pharmacology 0 works
- 10 Complementary and Alternative Medicine Studies Complementary and alternative medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Retriev Technologies (United States)'s research output changed?
Output in 2018–2022 was 33% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Anaheim
- Anaheim University
- Isuzu Motors (United States)
- Kaiser Permanente Anaheim Medical Center
- Optical Sciences Company (United States)
- Bethesda University
- South Baylo University
- College Of Certified Psychophysiologists
- Anaheim Clinical Trials
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.